Drug
CNTO6785 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
- CNTO 6785
- 1
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Janssen Research & Development, LLC (2) · Janssen-Cilag International NV (1)
Studies
Open first, then newest update. How each study uses CNTO6785 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedPhase 2Janssen Research & Development, LLCNCT01966549Written as CNTO 6785
- An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedPhase 2Janssen Research & Development, LLCNCT01909427Written as CNTO 6785 200 mg
- A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy VolunteersCompletedPhase 1Janssen-Cilag International NVNCT01288196Written as CNTO 6785 1 mg/kg IV